GlassScriptPhysician profile
Rajiv Handa
NPI 1790783538
$22,372.30
in general payments reported to CMS, 2019-2025
20 companies · $2,027 in 2025
The $2,027 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,328 · 2020: $663 · 2021: $11K · 2022: $1,722 · 2023: $1,943 · 2024: $2,935 · 2025: $2,027.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,718 · Travel and Lodging: $1,187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,717.53 |
| Travel and Lodging | $1,187.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $9,776.37 | 2019-2023 | (9520) Igt Devices Undivided |
| Boston Scientific Corporation | $3,058.37 | 2019-2025 | General - Therapies, Watchman Flx, Avvigo Guidance System |
| Abbott Laboratories | $2,498.85 | 2021-2025 | Aveir, Jot Dx, Mitraclip |
| Medtronic, INC. | $1,508.84 | 2021-2025 | Avalus, Endurant Iis, Azure Xt Dr Mri Surescan |
| Biosense Webster, INC. | $1,036.37 | 2021-2025 | Carto 3, Octaray Mapping Catheter, Qdot Micro Catheter |
| Janssen Pharmaceuticals, INC | $1,005.55 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $798.72 | 2019-2025 | Eliquis, Camzyos |
| Medtronic Vascular, INC. | $781.94 | 2019-2020 | |
| Pfizer INC. | $661.79 | 2019-2025 | |
| Kestra Medical Technology Services, INC. | $275.41 | 2022-2025 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $191.96 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $182.23 | 2019-2025 | Lifevest |
| Flowphysix INC | $150.05 | 2025 | Flowrunner |
| Genzyme Corporation | $125.00 | 2019 | |
| Abiomed | $95.47 | 2024 | Impella |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiofocus, INC. | $81.96 | 2019 | |
| Novartis Pharmaceuticals Corporation | $60.13 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.25 | 2019-2024 | Jardiance |
| Csl Behring | $20.84 | 2023 | Kcentra |
| Cook Medical LLC | $12.20 | 2024 | Evolution |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajiv Handa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.